Case Studies: Stahl's Essential Psychopharmacology: Volume 4
Children and Adolescents

A selection of stories presenting individualized treatment approaches for treating children and adolescents with psychiatric disorders.

Jeffrey R. Strawn (Author), Stephen M. Stahl (Author)

9781009048965, Cambridge University Press

Paperback / softback, published 9 November 2023

370 pages
22.8 x 13.9 x 1.6 cm, 0.55 kg

'This book walks with you hand-in-hand as it describes common clinical challenges encountered while psychiatrically treating a child or adolescent. This is a must-have for novice and experienced clinicians alike, to provide clear guidance on ways to address a wide range of clinical scenarios affecting youth. In today's complex and burdened healthcare environment, this essential psychopharmacology for child and adolescent psychiatry gives the busiest clinicians readily available tools to navigate complex scenarios with clear, sequential, and logical guidance. The clinical pearls are written in pragmatically and with adult learning principles in mind. Thank you, Drs Stahl and Strawn, for capitulating the wisdom of our field in such an accessible and engaging way.' Manpreet Kaur Singh, M.D., M.S., Associate Professor of Psychiatry and Behavioral Sciences, Stanford University, Stanford

This brand-new fourth volume in Stahl's Case Studies series presents a selection of clinical case studies in child and adolescent psychopharmacology, taken from Dr. Strawn's clinics and consultations. These cases illustrate common questions that are routinely asked by Dr. Strawn's peers in consultations and which represent dilemmas in the day-to-day practice of pediatric psychopharmacology. Followings a consistent, user-friendly layout, each case features icons, tips and questions about diagnosis and management as it progresses over time, a pre-case self-assessment question, followed by the correct answers at the end of the case. Formatted in alignment with the American Board of Psychiatry and Neurology's maintenance of psychiatry speciality certification, cases address multifaceted issues in a relevant and understandable way. Covering a wide-ranging and representative selection of clinical scenarios, each case is followed through the complete clinical encounter, from start to resolution, acknowledging all the complications, issues, decisions, twists and turns along the way.

Introduction
List of icons
Abbreviations
1. The case: the salutatorian who couldn't speak: Selective Serotonin Reuptake Inhibitor (SSRI)-refractory anxiety in an adolescent
2. The case: from anxious to activated: Selective Serotonin Reuptake Inhibitor (SSRI)-related activation
3. The case: the girl who couldn't sleep: Posttraumatic Stress Disorder (PTSD) in a young girl
4. The case: depressed and still depressed: Major Depressive Disorder (MDD) in an adolescent
5. The case: a 13-year-old adolescent who feels 'amazing': Selective Serotonin Reuptake Inhibitor (SSRI)-induced mania in an adolescent
6. The case: counting on a cure: Obsessive–Compulsive Disorder (OCD) in an adolescent
7. The case: struggles in the second grade: Attention-Deficit Hyperactivity Disorder (ADHD) in a child
8. The case: from prodrome to psychosis: early-onset schizophrenia
9. The case: too much, too little, or just right? lithium dosing in an adolescent
10. The case: tic, tic, tic: motor and vocal tics in a boy
11. The case: how slow can you go? Selective Serotonin Reuptake Inhibitor (SSRI) withdrawal and discontinuation in an adolescent
12. The case: the adolescent who doesn't eat: anorexia nervosa in an adolescent
13. The case: high or higher antidepressant concentrations? cannabis-related drug interactions in an adolescent
14. The case: the boy whose bed was always wet: nocturnal enuresis in a child
15. The case: counting sheep and counting treatment trials: insomnia disorder in an adolescent
16. The case: Second-Generation Antipsychotics (SGAs), side effects, and the autism spectrum: SGA-related side effects in a boy with Autism Spectrum Disorder (ASD)
17. The case: the 'standard treatment' is earning a 'D': treatment-resistant schizophrenia
18. The case: symptoms, side effects, or both? Selective Serotonin Reuptake Inhibitor (SSRI) tolerability and physical symptoms in an anxious adolescent
Index.

Subject Areas: Clinical psychology [MMJ]